TScan Therapeutics, Inc.

NASDAQ:TCRX

4.75 (USD) • At close October 29, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q12019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 242.159140.513133.359155.193208.84295.608120.027137.306125.603140.838161.405182.312106.197121.50134.791-41.7645.89
Short Term Investments 55.51722.2758.68560.230000000000083.5280
Cash and Short Term Investments 297.676162.783192.044155.193208.84295.608120.027137.306125.603140.838161.405182.312106.197121.50134.79141.7645.89
Net Receivables 000031.92600000000004.3160
Inventory 0000-33.376000000000000
Other Current Assets 1.8541.9382.1932.1441.455.2994.13.8713.7574.9114.2494.6913.8732.3721.654-4.3160
Total Current Assets 299.53164.721194.237155.193208.84295.608120.027141.177129.36145.749165.654187.003110.07123.87336.44541.7645.89
Non-Current Assets:
Property, Plant & Equipment, Net 68.56469.43371.23467.13468.02766.93369.20214.70215.55315.81417.25617.12516.63615.18312.53200
Goodwill 00000000000000000
Intangible Assets 00000000000000000
Goodwill and Intangible Assets 00000000000000000
Long Term Investments 5.0315.0315.0315.0315.0315.0315.03705.0375.0315.1970.5950.5950.761000
Tax Assets 0000000000000002.3150
Other Non-Current Assets 1.7461.6471.64764.02135.0236.0054.8259.5752.4651.6100.1662.7061.1230.761-44.0790
Total Non-Current Assets 75.34176.11177.912136.186108.08177.96979.06424.27723.05522.45522.45317.88619.93717.06713.293-41.7640
Total Assets 374.871240.832272.149291.379316.923173.577199.091165.454152.415168.204188.107204.889130.007140.9449.738351.784411.898
Liabilities & Equity:
Current Liabilities:
Account Payables 3.112.1232.3743.1963.3942.7732.9122.7083.0962.8861.7655.0723.5473.5742.9100
Short Term Debt 13.9510.1356.5935.4864.2093.8363.6811.7951.7461.6981.6511.621.5751.531.415109.067108.866
Tax Payables 00000000000000000
Deferred Revenue 10.70410.43510.13715.21219.21103.8745.9328.1710.86911.4111.96711.74611.38210.62700
Other Current Liabilities 10.8088.78610.7169.2578.3047.4386.8386.1594.1583.0126.5174.2853.7492.3522.49400
Total Current Liabilities 38.57231.47929.8233.15135.11814.04717.30516.59417.1718.46521.34322.94420.61718.83817.446109.067108.866
Non-Current Liabilities:
Long Term Debt 20.11223.44926.781.49783.5381.47682.30332.1053.4963.9484.3924.7915.2115.6196.01900
Deferred Revenue Non-Current 3.9554.7585.6227.7587.644000001.4972.8444.566.7568.81600
Deferred Tax Liabilities Non-Current 053.4210000000000159.411159.41159.6811.5050
Other Non-Current Liabilities 57.0114.75859.140.0120.0240.0360.0490.0970.0970.0970.0970.2360.2380.2380.238107.562108.866
Total Non-Current Liabilities 81.07886.38691.46289.26791.19881.51282.35232.2023.5934.0455.9867.871169.42172.02474.754109.067108.866
Total Liabilities 119.65117.865121.282122.418126.31695.55999.65748.79620.76322.5127.32930.815190.037190.86292.2196.879182.443
Equity:
Preferred Stock 00000000000204.889159.411159.41159.68159.6810
Common Stock 0.0060.0050.0050.0050.0050.0030.0030.0030.0030.0030.0030.0030.0010.0010.0010.030.03
Retained Earnings -309.4-277.739-247.597-227.984-204.987-180.942-158.379-139.656-123.411-108.314-92.158-77.958-62.119-51.445-43.533-154.9050
Accumulated Other Comprehensive Income/Loss 0-00000-00000-204.889-159.4110-59.681-17.1380
Other Total Stockholders Equity 564.615400.701398.459396.94395.589258.957257.81256.311255.06254.005252.933252.0292.088-157.889-58.611-0.03-0.03
Total Shareholders Equity 255.221122.967150.867168.961190.60778.01899.434116.658131.652145.694160.778174.074-60.03-49.922-42.46242.5430.03
Total Equity 255.221122.967150.867168.961190.60778.01899.434116.658131.652145.694160.778174.074-60.03-49.922-42.46242.5430.03
Total Liabilities & Shareholders Equity 374.871240.832272.149291.379316.923173.577199.091165.454152.415168.204188.107204.889130.007140.9449.73842.543411.898